Psychosocial issues following a positive result of genetic testing for BRCA1 and BRCA2 mutations: findings from a focus group and a needs-assessment survey

Di Prospero, Lisa S.; Seminsky, Maureen; Honeyford, Joanne; Doan, Brian; Franssen, Edmee; Meschino, Wendy; Chart, Pamela; Warner, Ellen
April 2001
CMAJ: Canadian Medical Association Journal;4/03/2001, Vol. 164 Issue 7, p1005
Academic Journal
Interpretation: Adequate resources must be made available to clinical programs providing BRCA1 and BRCA2 mutation testing to ensure appropriate pretest counselling and timely availability of results. Organization of support groups for people found to have the gene mutations should be a priority for these programs.


Related Articles

  • Cancer watch: Battling biology.  // U.S. News & World Report;10/3/94, Vol. 117 Issue 13, p16 

    Discusses a woman's lifetime risk for developing ovarian and breast cancer. Details on three reports, each linking cancer in women to outside forces, that offer hope for ways to battle the disease; Studies on exercise, diet and fertility drugs such as clomiphene.

  • Re: Prospective study of serum micronutrients and ovarian cancer. Gerber, Mariette; Saintot, Monique // JNCI: Journal of the National Cancer Institute;04/16/97, Vol. 89 Issue 8, p581 

    Supports the finding of Anthony J. Alberg and Kathy J. Helzlsouer that high serum cholesterol levels is a risk in breast cancer. Relation of abdominal obesity to hyperinsulinemia and insulin resistance; Relationship between serum cholesterol levels and ovarian cancer.

  • Early-Onset Breast Cancer and BRCA Mutations.  // JNCI: Journal of the National Cancer Institute;3/19/2003, Vol. 95 Issue 6, p417 

    Discusses the abstract of the article 'Familial risks, early-onset breast cancer, and BRCA1 and BRCA2 germline mutations,' by Gillian S. Dite, Mark A. Jenkins and colleagues, published in the March 19, 2003 issue of the 'Journal of the National Cancer Institute.' Risk factors for early-onset...

  • Familial Risks, Early-Onset Breast Cancer, and BRCA1 and BRCA2 Germline Mutations. Dite, Gillian S.; Jenkins, Mark A.; Southey, Melissa C.; Hocking, Jane S.; Giles, Graham G.; McCredie, Margaret R.E.; Venter, Deon J.; Hopper, John L. // JNCI: Journal of the National Cancer Institute;3/19/2003, Vol. 95 Issue 6, p448 

    Background: Having a family history of breast cancer, particularly if it involves early-onset disease, is a risk factor for breast cancer, but little is known about specific causes of this association. Consequently, we studied mothers, sisters, and aunts of an age-stratified sample of 1567...

  • Association of five single nucleotide polymorphisms at 6q25.1 with breast cancer risk in northwestern China. Long Zhou; Na He; Tian Feng; Tingting Geng; Tianbo Jin; Chao Chen // American Journal of Cancer Research;2015, Vol. 5 Issue 8, following p2467 

    CCDC170 and ESR1, located at 6q25.1, were associated with breast cancer (BC) risk by genome-wide association studies. Our goal was to validate the association between CCDC170-ESR1 polymorphisms and BC risk in the population of northwestern China. A case-control study of 551 patients with BC and...

  • MicroRNA-based molecular classification of non-BRCA1/2 hereditary breast tumours. Tanic, M; Andrés, E; M Rodriguez-Pinilla, S; Marquez-Rodas, I; Cebollero-Presmanes, M; Fernandez, V; Osorio, A; Benítez, J; Martinez-Delgado, B // British Journal of Cancer;11/12/2013, Vol. 109 Issue 10, p2724 

    Background:Hereditary breast cancer comprises 5-10% of all breast cancers. Mutations in two high-risk susceptibility genes, BRCA1 and BRCA2, along with rare intermediate-risk genes and common low-penetrance alleles identified, altogether explain no more than 45% of the high-risk breast cancer...

  • Large BRCA1 and BRCA2 genomic rearrangements in Polish high-risk breast and ovarian cancer families. Rudnicka, Helena; Debniak, Tadeusz; Cybulski, Cezary; Huzarski, Tomasz; Gronwald, Jacek; Lubinski, Jan; Gorski, Bohdan // Molecular Biology Reports;Dec2013, Vol. 40 Issue 12, p6619 

    BRCA1 and BRCA2 are two major genes associated with familial breast and ovarian cancer susceptibility. In Poland standard BRCA gene test is usually limited to Polish founder BRCA1 mutations: 5382insC, C61G and 4153delA. To date, just a few single large genomic rearrangements (LGRs) of BRCA1 gene...

  • Rare variants in XRCC2 as breast cancer susceptibility alleles. Hilbers, Florentine S.; Wijnen, Juul T.; Hoogerbrugge, Nicoline; Oosterwijk, Jan C.; Collee, Margriet J.; Peterlongo, Paolo; Radice, Paolo; Manoukian, Siranoush; Feroce, Irene; Capra, Fabio; Couch, Fergus J.; Xianshu Wang; Guidugli, Lucia; Offit, Kenneth; Shah, Sohela; Campbell, Ian G.; Thompson, Ella R.; James, Paul A.; Trainer, Alison H.; Gracia, Javier // Journal of Medical Genetics;Oct2012, Vol. 49 Issue 10, p618 

    Background Recently, rare germline variants in XRCC2 were detected in non-BRCA1/2 familial breast cancer cases, and a significant association with breast cancer was reported. However, the breast cancer risk associated with these variants needs further evaluation. Methods The coding regions and...

  • OGG1 Mutations and Risk of Female Breast Cancer: Meta-Analysis and Experimental Data. Ali, Kashif; Mahjabeen, Ishrat; Sabir, Maimoona; Mehmood, Humera; Kayani, Mahmood Akhtar // Disease Markers;5/19/2015, p1 

    In first part of this study association between OGG1 polymorphisms and breast cancer susceptibility was explored by meta-analysis. Second part of the study involved 925 subjects, used for mutational analysis of OGG1 gene using PCR-SSCP and sequencing. Fifteen mutations were observed, which...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics